Literature DB >> 19890219

Patient, physician, and payment predictors of statin adherence.

David C Chan1, William H Shrank, David Cutler, Saira Jan, Michael A Fischer, Jun Liu, Jerry Avorn, Daniel Solomon, M Alan Brookhart, Niteesh K Choudhry.   

Abstract

BACKGROUND: Although many patient, physician, and payment predictors of adherence have been described, knowledge of their relative strength and overall ability to explain adherence is limited.
OBJECTIVES: To measure the contributions of patient, physician, and payment predictors in explaining adherence to statins. RESEARCH
DESIGN: Retrospective cohort study using administrative data.
SUBJECTS: A total of 14,257 patients insured by Horizon Blue Cross Blue Shield of New Jersey who were newly prescribed a statin cholesterol-lowering medication. MEASURES: Adherence to statin medication was measured during the year after the initial prescription, based on proportion of days covered. The impact of patient, physician, and payment predictors of adherence were evaluated using multivariate logistic regression. The explanatory power of these models was evaluated with C statistics, a measure of the goodness of fit.
RESULTS: Overall, 36.4% of patients were fully adherent. Older patient age, male gender, lower neighborhood percent black composition, higher median income, and fewer number of emergency department visits were significant patient predictors of adherence. Having a statin prescribed by a cardiologist, a patient's primary care physician, or a US medical graduate were significant physician predictors of adherence. Lower copayments also predicted adherence. All of our models had low explanatory power. Multivariate models including patient covariates only had greater explanatory power (C = 0.613) than models with physician variables only (C = 0.566) or copayments only (C = 0.543). A fully specified model had only slightly more explanatory power (C = 0.633) than the model with patient characteristics alone.
CONCLUSIONS: Despite relatively comprehensive claims data on patients, physicians, and out-of-pocket costs, our overall ability to explain adherence remains poor. Administrative data likely do not capture many complex mechanisms underlying adherence.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19890219     DOI: 10.1097/MLR.0b013e3181c132ad

Source DB:  PubMed          Journal:  Med Care        ISSN: 0025-7079            Impact factor:   2.983


  72 in total

1.  Adherence to chronic disease medications among New York City Medicaid participants.

Authors:  Kelly A Kyanko; Robert H Franklin; Sonia Y Angell
Journal:  J Urban Health       Date:  2013-04       Impact factor: 3.671

2.  Influence of baseline low-density lipoprotein cholesterol values on statin therapy persistence.

Authors:  Anna Citarella; Marie Linder; Helle Kieler; Ingegärd Anveden Berglind; Anders Sundström; Björn Wettermark; Morten Andersen
Journal:  Eur J Clin Pharmacol       Date:  2015-12-16       Impact factor: 2.953

3.  Observing versus Predicting: Initial Patterns of Filling Predict Long-Term Adherence More Accurately Than High-Dimensional Modeling Techniques.

Authors:  Jessica M Franklin; William H Shrank; Joyce Lii; Alexis K Krumme; Olga S Matlin; Troyen A Brennan; Niteesh K Choudhry
Journal:  Health Serv Res       Date:  2015-04-16       Impact factor: 3.402

4.  Predictors of medication adherence in an urban Latino community with healthcare disparities.

Authors:  Jennifer A Colby; Fei Wang; Jyoti Chhabra; Rafael Pérez-Escamilla
Journal:  J Immigr Minor Health       Date:  2012-08

Review 5.  Statin Adherence: Does Gender Matter?

Authors:  Karen M Goldstein; Leah L Zullig; Lori A Bastian; Hayden B Bosworth
Journal:  Curr Atheroscler Rep       Date:  2016-11       Impact factor: 5.113

Review 6.  Impediments to adherence to post myocardial infarction medications.

Authors:  Nihar R Desai; Niteesh K Choudhry
Journal:  Curr Cardiol Rep       Date:  2013-01       Impact factor: 2.931

Review 7.  How do we improve patient compliance and adherence to long-term statin therapy?

Authors:  Patricia Maningat; Bruce R Gordon; Jan L Breslow
Journal:  Curr Atheroscler Rep       Date:  2013-01       Impact factor: 5.113

8.  Adherence to preventive statin therapy according to socioeconomic position.

Authors:  Helle Wallach-Kildemoes; Morten Andersen; Finn Diderichsen; Theis Lange
Journal:  Eur J Clin Pharmacol       Date:  2013-04-16       Impact factor: 2.953

9.  Patient characteristics associated with medication adherence.

Authors:  Sharon J Rolnick; Pamala A Pawloski; Brita D Hedblom; Stephen E Asche; Richard J Bruzek
Journal:  Clin Med Res       Date:  2013-04-11

10.  Effect of gender, caregiver, on cholesterol control and statin use for secondary prevention among hospitalized patients with coronary heart disease.

Authors:  Gmerice Hammond; Heidi Mochari-Greenberger; Ming Liao; Lori Mosca
Journal:  Am J Cardiol       Date:  2012-08-15       Impact factor: 2.778

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.